title: Advanced topics in evidence-based urologic oncology: economic analysis.
abstract: Urologists, regardless of whether they practice in the community or in an academic institution, make decisions not only about their individual patients but also about hospital and health care policy by providing input to various committees that influence the adoption of new diagnostic and therapeutic technology. In an era of increasing awareness of healthcare costs, economic analyses that consider not only the potential benefit and harm of a given intervention but also the costs of the intervention, are increasingly important. This review article introduces a framework to critically appraise an economic analysis for its validity, impact, and applicability to patient care using an example from the urologic literature.
authors: Department of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville, FL 32610, USA. bvogel@ehpr.ufl.edu
authors: Bruce
authors: B
authors: Vogel
authors: Scott M
authors: SM
authors: Gilbert
authors: Jill
authors: J
authors: Boylston Herndon
authors: Philippe
authors: P
authors: Dahm
mesh_terms: D003362:Cost-Benefit Analysis / Q000191:economics / Q000379:methods; D019317:Evidence-Based Medicine; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000532:radiotherapy; D061766:Proton Therapy; D019057:Quality-Adjusted Life Years; D011878:Radiotherapy / Q000191:economics / Q000379:methods; D014571:Urologic Neoplasms / Q000175:diagnosis / Q000628:therapy*; D011522:Protons
chemical_list: D011522:Protons